The goal of this activity is for learners to be better able to self-assess their ability to recognize recent data and treatment management considerations for relapse multiple myeloma.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/relapsed-refractory-multiple-myeloma-are-you-date-latest-2024a1000mt0
- Start Date: 2024-12-13 06:00:00
- End Date: 2024-12-13 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Janssen (Any division) - Amount: 17084.0 - Is Kind Support: False Source: Legend Biotech - Amount: 4272.0 - Is Kind Support: False Source: Sanofi S.A. - Amount: 17084.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest